Antao Xu

914 total citations · 1 hit paper
20 papers, 657 citations indexed

About

Antao Xu is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Antao Xu has authored 20 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Antao Xu's work include Inflammatory Myopathies and Dermatomyositis (4 papers), Immune Cell Function and Interaction (3 papers) and Inflammatory Bowel Disease (3 papers). Antao Xu is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (4 papers), Immune Cell Function and Interaction (3 papers) and Inflammatory Bowel Disease (3 papers). Antao Xu collaborates with scholars based in China, Rwanda and United States. Antao Xu's co-authors include Luoyan Ai, Jie Xu, Di Zhao, Zhihua Ran, Qing Zheng, Shuang Jin, Jun Shen, Mingming Zhu, Liangjing Lu and Xinyue Lian and has published in prestigious journals such as PLoS ONE, Gut and Scientific Reports.

In The Last Decade

Antao Xu

16 papers receiving 647 citations

Hit Papers

Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
    2020 362 citations Luoyan Ai, Antao Xu et al. Advances in experimental medicine and biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antao Xu China 8 246 231 210 132 112 20 657
Julian Ananiev Bulgaria 13 277 1.1× 203 0.9× 178 0.8× 124 0.9× 128 1.1× 73 752
I‐Tsu Chyuan Taiwan 17 150 0.6× 242 1.0× 337 1.6× 121 0.9× 46 0.4× 27 741
Ilinca Nicolae Romania 13 116 0.5× 174 0.8× 133 0.6× 151 1.1× 46 0.4× 45 568
Lingxiao Xu China 19 177 0.7× 313 1.4× 283 1.3× 102 0.8× 55 0.5× 49 843
Hai P. Nguyen United States 12 165 0.7× 419 1.8× 157 0.7× 107 0.8× 59 0.5× 19 798
Oksana Kowalczuk Poland 15 172 0.7× 215 0.9× 143 0.7× 131 1.0× 97 0.9× 51 720
Sagie Schif‐Zuck Israel 16 165 0.7× 286 1.2× 557 2.7× 72 0.5× 78 0.7× 25 890
Prabhakaran Kumar United States 13 219 0.9× 143 0.6× 413 2.0× 52 0.4× 52 0.5× 20 759
Andrew Cross United Kingdom 12 148 0.6× 334 1.4× 494 2.4× 77 0.6× 54 0.5× 22 824
Chuanwang Song China 14 116 0.5× 251 1.1× 585 2.8× 75 0.6× 113 1.0× 46 945

Countries citing papers authored by Antao Xu

Since Specialization
Citations

This map shows the geographic impact of Antao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antao Xu more than expected).

Fields of papers citing papers by Antao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antao Xu. The network helps show where Antao Xu may publish in the future.

Co-authorship network of co-authors of Antao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Antao Xu. A scholar is included among the top collaborators of Antao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antao Xu. Antao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Jingjing, Ran Wang, Jie Chen, et al.. (2025). Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome. Frontiers in Immunology. 16. 1604648–1604648.
3.
4.
Wu, Wanlong, Runci Wang, Yi Chen, et al.. (2024). Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19. Frontiers in Immunology. 15. 1295472–1295472. 1 indexed citations
5.
Xu, Antao & Qiong Fu. (2023). Heliotrope rash. BMJ. 382. e075978–e075978.
6.
Zhou, Mi, et al.. (2022). Behcet’s-like disease in a patient treated with Ixekizumab for chronic plaque psoriasis. Scandinavian Journal of Rheumatology. 51(4). 336–337. 6 indexed citations
7.
Fu, Yakai, Jia Li, Antao Xu, et al.. (2022). Ruxolitinib rescued the macrophage activation syndrome in adult-onset Still’s disease with delayed hypersensitivity reaction to tocilizumab. Lara D. Veeken. 62(7). e223–e225. 7 indexed citations
8.
Ai, Luoyan, Mingming Zhu, Shiyuan Lu, et al.. (2021). Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis. Gut. 70(12). 2261–2272. 42 indexed citations
9.
Xu, Antao, Xia Lv, Fang Du, & Min Dai. (2021). Cutaneous ulceration and digital gangrene in an anti-MDA5-positive overlap myositis. Lara D. Veeken. 60(12). 5880–5881. 1 indexed citations
10.
Ai, Luoyan, Antao Xu, & Jie Xu. (2020). Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond. Advances in experimental medicine and biology. 1248. 33–59. 362 indexed citations breakdown →
11.
12.
Xu, Antao, Yan Ye, Qiong Fu, et al.. (2020). Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease. Lara D. Veeken. 60(7). 3343–3351. 69 indexed citations
13.
Ai, Luoyan, Yiting Li, Haoyan Chen, et al.. (2018). Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome. International Journal of Cancer. 145(1). 206–220. 11 indexed citations
14.
Zhu, Mingming, et al.. (2018). Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging. Gastroenterology report. 7(1). 50–56. 7 indexed citations
15.
Jin, Shuang, Di Zhao, Jun Shen, et al.. (2017). Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification. Scientific Reports. 7(1). 43662–43662. 64 indexed citations
16.
Ai, Luoyan, Xiaohan Wang, Zhiwei Chen, et al.. (2016). A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling. Molecular and Cellular Biochemistry. 420(1-2). 73–83. 5 indexed citations
17.
Zhao, Di, Antao Xu, Mingming Zhu, et al.. (2015). WNT5A transforms intestinal CD8αα+ IELs into an unconventional phenotype with pro-inflammatory features. BMC Gastroenterology. 15(1). 173–173. 4 indexed citations
18.
Ai, Luoyan, Qingqing Xu, Changwei W. Wu, et al.. (2015). A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis. International Journal of Biological Sciences. 11(12). 1436–1446. 19 indexed citations
19.
Cao, Yuan, Di Zhao, Antao Xu, Jun Shen, & Zhihua Ran. (2015). Effects of Immunosuppressants on Immune Response to Vaccine in Inflammatory Bowel Disease. Chinese Medical Journal. 128(6). 835–838. 13 indexed citations
20.
Shen, Jun, Di Zhao, Antao Xu, et al.. (2014). Serological Investigation of Food Specific Immunoglobulin G Antibodies in Patients with Inflammatory Bowel Diseases. PLoS ONE. 9(11). e112154–e112154. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julian Ananiev Breakdown of academic impact, for papers by I‐Tsu Chyuan Breakdown of academic impact, for papers by Ilinca Nicolae Breakdown of academic impact, for papers by Lingxiao Xu Breakdown of academic impact, for papers by Hai P. Nguyen Breakdown of academic impact, for papers by Oksana Kowalczuk Breakdown of academic impact, for papers by Sagie Schif‐Zuck Breakdown of academic impact, for papers by Prabhakaran Kumar Breakdown of academic impact, for papers by Andrew Cross Breakdown of academic impact, for papers by Chuanwang Song
Rankless by CCL
2026